Animal Health Symposium Facilitated Roundtable Discussion

Gary Anderson, Kansas State University
Richard Brown, Boehringer Ingelheim Vetmedica Inc
Daryl Pint, Ceva Biomune
Prasad Saraph, Bayer Animal Health
Ron Wilms, Merck

Discussion will focus on the Animal Health Industry as it is today and where it will head in the future. Participants from the animal health industry have been invited to join in this discussion. Each person is a recognized leader in a national and global animal health company with facilities in this region. Each individual has a key role in the planning, operation and growth of their organization. These leaders will share their insight with the attendees on topics such as:

  • What is your company doing to decrease energy consumption?
  • Does your organization have a sustainability commitment and/or program?
  • What measures have you taken to build in flexibility in your facilities?
  • Is the quality of your organization being leveraged to recruit and retain the best employees?
  • What does your facility of the future look like and how does it function?

Attendees will walk away from this Roundtable with a better understanding of an industry whose continued success is vital to our present and future global economies.

Learning Objectives

  • Gain an understanding of the requirements and needs for designing, building and operating VDL's.
  • Learn about the significance of the KSU/NBAF collaboration and its important role in the Bio-Ag arena.
  • Learn what it takes to successfully operate a fully accredited VDL facility.
  • Understand some of the challenges are that KSU VDL faces.

Biography:

Dr. Gary Anderson is the Director of the Veterinary Diagnostic Laboratory (VDL) at Kansas State University in Manhattan, Kansas. Gary's primary responsibilities include the oversight of day-to-day operation. Gary's primary responsibilities includes the oversight of day-to-day operations of the VDL Lab. He set policies and procedures consistent with AAVLD accreditation requirements, establish vision and leadership for the Veterinary Diagnostic Laboratory, recruit faculty and staff, provide opportunities for faculty and staff growth and development, and prepare and manage budgets in consultation with the Dean of the College of Veterinary Medicine and the Head of Diagnostic Medicine and Pathobiology.

Richard Brown is the Senior Associate Director – US Engineering for Boehringer Ingelheim Vetmedica, Inc. (BIVI). He holds a BS in Mechanical Engineering from the University of Missouri and is a registered Professional Engineer in the state of Missouri. In his current role, Richard is responsible for all engineering functions at BIVI’s US sites, including capital budgeting, capital expenditures, project management, building automation, and long term forecast planning. For over 15 years, he has been involved with construction and project management of various types of facilities for both the human pharma and animal health sectors.

Daryl Pint, CEO of Ceva Biomune, has 33 years of industrial biotechnology management experience. Ceva, an animal health biological vaccine manufacturing company located in Lenexa has recently been ranked the third largest animal health company in Kansas City and has over 450 local employees. In addition to his professional achievements, Daryl is an active member of the Kansas City community. He is a board member of Animal Health Corridor, BioKansas and Grace Point Church. He is also active in workforce and talent development for biotechnology and is focused on creating opportunities for students in the industrialization of biotechnology and R&D.

Prasad Saraph – biography coming soon.

Ron Wilms is the Associate Director of Engineering for Merck Animal Health – DeSoto, KS. He is responsible for capital project management, construction and engineering for the 320 acre DeSoto vaccine manufacturing facility and research farm. Ron has a BS in Mechanical Engineering and an MS is Industrial and Manufacturing Systems Engineering from Kansas State University. He has over 30 years of industry experience in human health with the past 10 years in animal health biotechnology. Ron is currently involved extensively with infrastructure upgrades to the facility, new building construction and long range capacity planning.

 

Note: I2SL did not edit or revise abstract or biography text. Abstracts and biographies are displayed as submitted by the author(s).